Author, Subjects, Keywords

Cited Author

 
 
   » By Author or Editor
 » Browse Author by Alphabet
 » By Journal
 » By Subjects
 » Malaysian Journals
 » By Type
 » By Year
 » By Latest Additions
 
 
   » By Author
 » Top 20 Authors
 » Top 20 Article
 » Top Journal Cited
 » Top Article Cited
 » Journal Citation Statistics
 » Usage Since Sept 2007


 
 
 

Login | Create Account

Dialysis for End Stage Renal Disease: A Descriptive Study in Penang Hospital

Shaza A.M., and Rozina G., and Mohamed Izham M.I., and Syed Azhar S.S., (2005) Dialysis for End Stage Renal Disease: A Descriptive Study in Penang Hospital. Medical Journal of Malaysia, 60 (3). pp. 320-327. ISSN 0300-5283

Full text not available from this repository.

Affiliations

Universiti Sains Malaysia. 4-23 International House.
Hospital Penang. Nephrology Unit.
Universiti Sains Malaysia. School of Pharmaceutical Sciences. Sosial and Administrative Pharmacy Discipline.
Universiti Sains Malaysia. School of Pharmaceutical Sciences. Clinical Pharmacy Discipline.

Abstract

This research was carried out to study the characteristics of ESRD patients and the resources consumed with dialysis treatment as well as to assess the clinical outcomes of ESRD treatment in Penang Hospital. A total of 117 ESRD patients were studied over 30 months. 56.4% of the patients were male and the median age was 40. Diabetic nephropathy was the commonest cause of ESRD (29.9%). Hypertension was the predominant comorbidity (60.6%). A larger proportion started treatment with Continuous Ambulatory Peritoneal Dialysis (59.0%). At the end of the study period, 49.6% of the patients continued their treatment in the same modality and 27.4% died. Average Dialysis Adequacy (Kt/V) achieved was satisfactory, 2.29 in CAPD and 1.50 in Haemodialysis.

Item Type:Journal
Keywords:End stage renal disease, Hemodialysis, Continuous ambulatory peritoneal dialysis, Penang Hospital, Resources consumed.
Subjects:R Medicine, Dentistry, Pharmacy, Nursing
ID Code:5818

1. Sennfalt K, Magnusson M and Carlsson P: Comparison of Hemodialysis and Peritoneal Dialysis — A Cost —Utility Analysis. Peritoneal Dialysis International 2002; 22: 39-47.

2. Russell A, Remington P, Alessio DD, Brazy P: Increasing Incidence of End Stage Renal Disease in Wisconsin: An Unintended Consequence of Increased Survival?. Wisconsin Medical Journal 2001; 100 (6).

3. Macleod A, Grant A, Donaldson C et al. : Effectiveness and Efficiency of Methods of Dialysis Therapy for ESRD: Systematic Review. Health Technology Assessment 1998; 2(5).

4. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Identifies Risks, Measures, Burden of Kidney and Urologic Disease. Winter 2001-2002.

5. Lim TO, Lim YN: Ninth Report of The Malaysian Dialysis and Transplantation Registry 2001 . http://www.crc.gov.my/nrr

6. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). NIH Publication 2002; 2: 4358.

7. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification, Am J Kidney Dis Feb. 2002; 39(2) supp. (1): s1-246.

8. Nissenson AR and Fine RN: Dialysis Therapy. 3rd ed. Philadelphia. Hanley & Belfus, Inc 2002.

9. Jungers P, Choukroun G, Robino C et al.: Epidemiology of End-Stage Renal Disease in the Ile-de-France: A Prospective Study in 1998. Nephrol Dial Transplant 2000; 12: 2000-2006.

10. El-Reshaid K, Johny KV, Sugathan TN, Hakim A, Georgous M and Nampoory MR: End-Stage Renal Disease and Renal Replacement Therapy in Kuwait-- Epidemiological Profile over the Past 4 1/2 years. Nephrol Dial Transplant 1994; 9(5): 532-38.

11. Shinzato T, Nakai S, Akiba T et al. : Current Status of Renal Replacement Therapy in Japan: Results of the Annual Survey of the Japanese Society for Dialysis Therapy. Nephrol Dial Transplant 1997; 12: 889-98.

12. United States Renal Data System (USRDS). Annual Data Report 1999. Am J Kidney Dis 1999; 34 [suppl 1], S40- S151.

13. Clark WF, Churchill DN, Forwell L, Macdonald G, Foster S: To Pay or not to Pay? A Decision and Cost Utility Analysis of Angiotensin-Converting-Enzyme Inhibitor Therapy for Diabetic Nephropathy. CMAJ 2000: 162(2): 195-8.

14. Anderson J: ACE inhibitors Vs ARBs for Diabetic Nephropathy in Type 2 Diabetes. DUR Report 2002. The UNM College of Pharmacy.

15. Bloembergen WE, Port FK, Mauger EA and Wolfe RA: A Comparison of Mortality between Patients Treated with Hemodialysis and Peritoneal Dialysis. Journal of the American Society of Nephrology 1995: 6: 177-83.

16. Wong HS, Ghazali A, Zaki Morad MZ: Renal Replacement Therapy Practice Guidelines. Ministry of Health, Malaysia 1999.

17. Sevick M, Tell GS, Shumaker SA et al. : The Kidney Outcome Prediction and Evaluation (KOPE) Study: A Prospective Cohort Investigation of Patients Undergoing Hemodialysis Study Design and Baseline Characteristics, Ann Epidemiology 1998; 8: 192-200.

Repository Staff Only: item control page
 
 
 
 
 
 
© Copyright 2007 MyAIS Faculty of Computer Science and Information Technology, University of Malaya – All Rights Reserved. Malaysian Abstracting and Indexing System is powered by EPrints 3 which is developed by the School of Electronics and Computer Science at the University of Southampton. More information and software credits.